ArticleFrontiers in immunology2022

Immunotherapy or targeted therapy as the first-line strategies for unresectable hepatocellular carcinoma: A network meta-analysis and cost-effectiveness analysis.

Kun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.